Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spyridon Michopoulos

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Annals of Gastroenterology|May 15, 2025
Induction with upadacitinib in Crohn's disease: real-world experience from an early-access program in GreeceEvgenia Papathanasiou, Alexandros Ioannou, Pavlos Pardalis, et al.
Inflammatory Bowel Diseases|May 27, 2021
Response to Anti-α4β7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at BaselineMaria Gazouli, Nikolas Dovrolis, Marilena M Bourdakou, et al.
Crohn'S & Colitis 360|February 13, 2023
The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn's Disease With Poor Prognostic Factors: The MODIFY StudyGerassimos J Mantzaris, Christos Zeglinas, Angeliki Theodoropoulou, et al.
Annals of Gastroenterology|May 5, 2023
Sedation during endoscopic procedures: a Hellenic Society of Gastroenterology Position StatementNikolaos Viazis, John Vlachogiannakos, Periklis Apostolopoulos, et al.
Journal of Crohn'S & Colitis|March 31, 2021
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE StudyBrian Bressler, Andres Yarur, Mark S Silverberg, et al.
Journal of Clinical Medicine|February 15, 2022
Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel DiseaseEleni Orfanoudaki, Eirini Zacharopoulou, Vassiliki Kitsou, et al.
Journal of Crohn'S & Colitis|January 2, 2016
Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel DiseaseKonstantinos Karmiris, Anastasios Avgerinos, Aikaterini Tavernaraki, et al.
The Lancet. Gastroenterology & Hepatology|September 11, 2021
Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysisLia C M J Goltstein, Karina V Grooteman, Alba Rocco, et al.
Digestive Diseases and Sciences|March 22, 2021
Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD CohortGiorgos Bamias, Georgios Kokkotis, Michalis Gizis, et al.
World Journal of Gastroenterology|November 24, 2025
Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up studyMaria Tzouvala, Eirini Zacharopoulou, Maria Kalafateli, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Annals of Gastroenterology|May 15, 2025
Induction with upadacitinib in Crohn's disease: real-world experience from an early-access program in GreeceEvgenia Papathanasiou, Alexandros Ioannou, Pavlos Pardalis, et al.
Inflammatory Bowel Diseases|May 27, 2021
Response to Anti-α4β7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at BaselineMaria Gazouli, Nikolas Dovrolis, Marilena M Bourdakou, et al.
Crohn'S & Colitis 360|February 13, 2023
The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn's Disease With Poor Prognostic Factors: The MODIFY StudyGerassimos J Mantzaris, Christos Zeglinas, Angeliki Theodoropoulou, et al.
Annals of Gastroenterology|May 5, 2023
Sedation during endoscopic procedures: a Hellenic Society of Gastroenterology Position StatementNikolaos Viazis, John Vlachogiannakos, Periklis Apostolopoulos, et al.
Journal of Crohn'S & Colitis|March 31, 2021
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE StudyBrian Bressler, Andres Yarur, Mark S Silverberg, et al.
Journal of Clinical Medicine|February 15, 2022
Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel DiseaseEleni Orfanoudaki, Eirini Zacharopoulou, Vassiliki Kitsou, et al.
Journal of Crohn'S & Colitis|January 2, 2016
Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel DiseaseKonstantinos Karmiris, Anastasios Avgerinos, Aikaterini Tavernaraki, et al.
The Lancet. Gastroenterology & Hepatology|September 11, 2021
Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysisLia C M J Goltstein, Karina V Grooteman, Alba Rocco, et al.
Digestive Diseases and Sciences|March 22, 2021
Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD CohortGiorgos Bamias, Georgios Kokkotis, Michalis Gizis, et al.
World Journal of Gastroenterology|November 24, 2025
Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up studyMaria Tzouvala, Eirini Zacharopoulou, Maria Kalafateli, et al.
Pageof 4